Related Experiment Video
Updated: Jun 11, 2026
10:00
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Interferon-tau: current applications and potential in antiviral therapy
1Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814, USA. Thomas.Chon@Gmail.com
Summary
Interferon-tau (IFN-tau), an ovine pregnancy protein, shows potent antiviral activity against human viruses like HIV and HPV. It offers a potentially safer alternative to interferon-alpha for treating viral infections due to lower toxicity.
Area of Science:
- Immunology
- Virology
- Reproductive Biology
Background:
- Interferon-tau (IFN-tau) is an ovine pregnancy-associated protein produced by the trophoblast.
- IFN-tau plays a role in maintaining the corpus luteum during ovine pregnancy and serves as an early pregnancy marker.
- As a type I interferon, IFN-tau exhibits antiviral properties.
Purpose of the Study:
- To investigate the potential of ovine Interferon-tau (IFN-tau) as a therapeutic agent against human viral infections.
- To evaluate the antiviral efficacy and safety profile of IFN-tau in comparison to existing interferon therapies.
Main Methods:
- In vitro studies were conducted to assess the antiviral activity of IFN-tau.
- Replication of various human viruses, including human immunodeficiency virus (HIV), feline immunodeficiency virus (FIV), and human papillomavirus (HPV), was measured in the presence of IFN-tau.
- Species cross-reactivity and toxicity associated with IFN-tau were evaluated.
Main Results:
- IFN-tau demonstrated significant efficacy in reducing the replication of HIV, FIV, and HPV in vitro.
- The protein exhibits broad species cross-reactivity, indicating potential applicability beyond ovine species.
- IFN-tau displayed comparable antiviral activity to interferon-alpha but with a notably lower toxicity profile.
Conclusions:
- Ovine Interferon-tau (IFN-tau) possesses potent in vitro antiviral activity against a range of human viruses.
- Its high species cross-reactivity and reduced toxicity suggest IFN-tau as a promising alternative to interferon-alpha for antiviral therapy.
- Further research into IFN-tau could lead to novel treatments for viral infections.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.